文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嗅神经母细胞瘤晚期颈部转移的挽救性治疗:一项荟萃分析

Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis.

作者信息

Gore Mitchell R, Zanation Adam M

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7070, USA.

出版信息

Arch Otolaryngol Head Neck Surg. 2009 Oct;135(10):1030-4. doi: 10.1001/archoto.2009.143.


DOI:10.1001/archoto.2009.143
PMID:19841344
Abstract

OBJECTIVE: Esthesioneuroblastoma (ENB) is an uncommon tumor of the sinonasal region with a 20% rate of neck metastases. To our knowledge, the rate of neck metastases occurring 6 or more months after diagnosis has not been well characterized. The rate of successful salvage of these late neck metastases, defined in this study as disease-free survival for at least 1 year, has not been previously reported. DESIGN: Meta-analysis examining 33 articles published since 1990. PATIENTS: A total of 678 patients with ENB with 79 patients with neck metastases occurring 6 or more months after the initial diagnosis. INTERVENTIONS: Patients were grouped according to treatment with surgery, radiotherapy, or combined surgery and radiotherapy. MAIN OUTCOME MEASURES: The rate of successful salvage of late neck metastases, defined as disease-free survival for at least 1 year, was compared for the 3 treatment groups. RESULTS: The rate of cervical metastases was 20.2%, with a 12.4% rate of late neck metastases. The combined successful salvage rate for late neck metastases with surgery, radiation, or combined therapy was 31.2%. An odds ratio (OR) analysis revealed that surgery plus radiation provided a statistically significant increase in the rate of successful salvage in patients with late neck metastases, with an OR of 8.6 vs single modality therapy and a number-needed-to-treat of 3. We found no difference in the OR for successful salvage for surgery alone vs radiation alone (OR, 1.5). CONCLUSION: Treatment of neck metastases occurring 6 or more months after an initial diagnosis of ENB with combined surgery and radiotherapy provides a statistically significant survival advantage vs single-modality therapy.

摘要

目的:嗅神经母细胞瘤(ENB)是一种鼻窦区域的罕见肿瘤,颈部转移率为20%。据我们所知,诊断后6个月或更长时间出现颈部转移的发生率尚未得到充分描述。这些晚期颈部转移的成功挽救率,在本研究中定义为无病生存至少1年,此前尚未见报道。 设计:对1990年以来发表的33篇文章进行荟萃分析。 患者:共有678例ENB患者,其中79例在初次诊断后6个月或更长时间出现颈部转移。 干预措施:根据手术、放疗或手术联合放疗进行分组治疗。 主要观察指标:比较3个治疗组晚期颈部转移的成功挽救率,定义为无病生存至少1年。 结果:颈部转移率为20.2%,晚期颈部转移率为12.4%。手术、放疗或联合治疗晚期颈部转移的联合成功挽救率为31.2%。比值比(OR)分析显示,手术加放疗使晚期颈部转移患者的成功挽救率有统计学意义的提高,OR为8.6,而单模式治疗为1,需治疗人数为3。我们发现单纯手术与单纯放疗的成功挽救OR无差异(OR,1.5)。 结论:对于初次诊断ENB后6个月或更长时间出现的颈部转移,手术联合放疗的治疗与单模式治疗相比,具有统计学意义的生存优势。

相似文献

[1]
Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis.

Arch Otolaryngol Head Neck Surg. 2009-10

[2]
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.

Head Neck. 2003-7

[3]
Esthesioneuroblastoma: is there a need for elective neck treatment?

Int J Radiat Oncol Biol Phys. 2011-6-15

[4]
Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.

J Craniomaxillofac Surg. 2008-1

[5]
Combined modality therapy of esthesioneuroblastoma.

Otolaryngol Head Neck Surg. 2007-6

[6]
Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.

Auris Nasus Larynx. 2007-12

[7]
Efficacy of surgical salvage for advanced neck metastases after radiotherapy failure.

J Otolaryngol. 2000-12

[8]
When, how and why to treat the neck in patients with esthesioneuroblastoma: a review.

Eur Arch Otorhinolaryngol. 2010-8-13

[9]
Esthesioneuroblastoma: a meta-analysis and review.

Lancet Oncol. 2001-11

[10]
Esthesioneuroblastoma: the Northwestern University experience.

Laryngoscope. 2003-1

引用本文的文献

[1]
The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.

Cancer Med. 2024-3

[2]
Update on olfactory neuroblastoma.

Virchows Arch. 2024-4

[3]
Esthesioneuroblastoma: Management of the N0 neck.

J Neurol Surg Rep. 2023-8-4

[4]
Regional Recurrences and Hyams Grade in Esthesioneuroblastoma.

J Neurol Surg B Skull Base. 2020-10-5

[5]
The Treatment Outcomes of Olfactory Neuroblastoma Patients With Frontal Lobe Invasion.

Front Oncol. 2021-7-5

[6]
Esthesioneuroblastoma: Summary of Single-center Experiences with Focus on Adjuvant Therapy and Overall Survival.

Cureus. 2019-6-13

[7]
Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.

Int Forum Allergy Rhinol. 2019-6-28

[8]
Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives.

J Neurol Surg B Skull Base. 2018-6

[9]
Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma.

J Neurol Surg B Skull Base. 2017-2

[10]
Atypical esthesioneuroblastoma invading oral cavity: a case report and review of the literature.

Diagn Pathol. 2014-1-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索